Colony Group’s QuidelOrtho QDEL Stock Holding History

Colony Group’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,190	Closed	-$213K	–	818
2022 Q2	$213K	Buy	+2,190	New	+$223K	﹤0.01%	767

Other funds holding QDEL

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Colony Group's QDEL Position: Q3 2022 in Review

Colony Group sold out of QuidelOrtho (QDEL) in Q3 2022, closing a stake of 2,190 shares — an estimated $213K sold.

Colony Group first reported a position in QDEL in Q2 2022 and held it in 1 quarter. The position peaked at $213K in Q2 2022. 315 funds tracked by Wall St. Rank hold QDEL as of Q3 2022.

Colony Group reported no remaining QuidelOrtho position as of Q3 2022 after selling out during the quarter.
Colony Group sold 2,190 QuidelOrtho shares in Q3 2022, an estimated $213K.
Colony Group first reported a position in QuidelOrtho in Q2 2022 and held it in 1 quarter.
Colony Group's QuidelOrtho position peaked at $213K in Q2 2022.
315 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2022.

Based on Colony Group's 13F filing for Q3 2022, filed 15 Nov 2022.